XML 53 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Stock-based compensation expense is included on the Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) based upon the job functions of the employees receiving the grants.  Compensation expense related to EOG's stock-based compensation plans for the years ended December 31, 2020, 2019 and 2018 was as follows (in millions):
 202020192018
Lease and Well$52 $56 $51 
Gathering and Processing Costs1 1 1 
Exploration Costs21 26 25 
General and Administrative72 92 78 
Total$146 $175 $155 
Vesting Schedule
The vesting schedules for grants of stock options, SARs, restricted stock and restricted stock units, and performance units are generally as follows:
Grant TypeVesting Schedule
Stock Options/SARsVesting in increments of one-third on each of the first three anniversaries, respectively, of the date of grant
Restricted Stock/Restricted Stock Units"Cliff" vesting three years from the date of grant
Performance Units
"Cliff" vesting on the February 28th following the three-year performance period and the Compensation Committee's certification of the applicable performance multiple
Weighted Average Fair Values and Valuation Assumptions
Weighted average fair values and valuation assumptions used to value stock option, SAR and ESPP grants for the years ended December 31, 2020, 2019 and 2018 were as follows:
 Stock Options/SARsESPP
 202020192018202020192018
Weighted Average Fair Value of Grants
$11.06 $19.49 $33.46 $19.14 $22.83 $25.75 
Expected Volatility44.47 %32.02 %28.23 %53.48 %34.78 %24.59 %
Risk-Free Interest Rate0.21 %1.69 %2.68 %0.90 %2.27 %1.89 %
Dividend Yield3.27 %1.39 %0.72 %2.27 %1.04 %0.64 %
Expected Life5.2 years5.1 years5.0 years0.5 years0.5 years0.5 years
Schedule of Share Based Compensation Arrangement By Share Based Payment Award
The following table sets forth the stock option and SAR transactions for the years ended December 31, 2020, 2019 and 2018 (stock options and SARs in thousands):
 202020192018
 Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price		Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price		Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price
Outstanding at January 19,395 $94.53 8,310 $96.90 9,103 $83.89 
Granted1,996 37.63 1,965 75.39 1,906 126.49 
Exercised (1)
(23)69.59 (606)61.43 (2,493)72.21 
Forfeited(1,182)88.93 (274)102.57 (206)94.43 
Outstanding at December 3110,186 84.08 9,395 94.53 8,310 96.90 
Stock Options/SARs Exercisable at December 31
6,343 96.41 5,275 94.21 3,969 85.82 
(1)The total intrinsic value of stock options/SARs exercised during the years 2020, 2019 and 2018 was $0.4 million, $14 million and $118 million, respectively.  The intrinsic value is based upon the difference between the market price of the Common Stock on the date of exercise and the grant price of the stock options/SARs.
Stock Options and SARs Outstanding and Exercisable
The following table summarizes certain information for the stock options and SARs outstanding and exercisable at December 31, 2020 (stock options and SARs in thousands):
Stock Options/SARs OutstandingStock Options/SARs Exercisable
Range of
Grant
Prices		Stock
Options/
SARs		Weighted
Average
Remaining
Life
(Years)		Weighted
Average
Grant
Price
 
 
Aggregate
Intrinsic
Value(1)
Stock
Options/
SARs		Weighted
Average
Remaining
Life
(Years)		Weighted
Average
Grant
Price
 
 
Aggregate
Intrinsic
Value (1)
$ 34.00 to $  43.991,974 7$37.43  10 1$37.44   
44.00 to     74.99872 269.37  846 269.47   
   75.00 to     75.991,863 675.09  636 575.09   
   76.00 to     95.991,242 394.47  1,215 394.63   
   96.00 to   101.992,477 397.95  2,457 397.95   
 102.00 to   129.991,758 5126.44 1,179 5126.37 
 10,186 484.08 $24,578 6,343 396.41 $124 
(1)Based upon the difference between the closing market price of the Common Stock on the last trading day of the year and the grant price of in-the-money stock options and SARs, in thousands.
ESPP Activity The following table summarizes ESPP activity for the years ended December 31, 2020, 2019 and 2018 (in thousands, except number of participants):
 202020192018
Approximate Number of Participants2,063 1,998 1,934 
Shares Purchased377 224 180 
Aggregate Purchase Price$16,103 $16,533 $14,887 
Restricted Stock and Restricted Stock Unit Transactions
The following table sets forth the restricted stock and restricted stock unit transactions for the years ended December 31, 2020, 2019 and 2018 (shares and units in thousands):
 202020192018
 Number of Shares and UnitsWeighted Average Grant Date Fair ValueNumber of Shares and UnitsWeighted Average Grant Date Fair ValueNumber of Shares and UnitsWeighted Average Grant Date Fair Value
Outstanding at January 14,546 $90.16 3,792 $96.64 3,905 $88.57 
Granted1,488 38.10 1,749 80.01 812 117.55 
Released (1)
(1,213)85.92 (855)96.93 (740)78.16 
Forfeited(79)86.52 (140)97.54 (185)92.12 
Outstanding at December 31 (2)
4,742 74.97 4,546 90.16 3,792 96.64 
(1)The total intrinsic value of restricted stock and restricted stock units released during the years ended December 31, 2020, 2019 and 2018 was $48 million, $70 million and $84 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date restricted stock and restricted stock units are released.
(2)The total intrinsic value of restricted stock and restricted stock units outstanding at December 31, 2020, 2019 and 2018 was $236 million, $381 million and $331 million, respectively. The intrinsic value is based on the closing market price of the Common Stock on the last trading day of the year.
Weighted Average Fair Values and Valuation Assumptions for Performance Units/Stocks Weighted average fair values and valuation assumptions used to value Performance Awards during the years ended December 31, 2020, 2019 and 2018 were as follows:
 202020192018
Weighted Average Fair Value of Grants$42.77 $79.98 $136.74 
Expected Volatility47.27 %29.20 %29.92 %
Risk-Free Interest Rate0.16 %1.51 %2.85 %
Performance Unit and Performance Stock Transactions
The following table sets forth the Performance Award transactions for the years ended December 31, 2020, 2019 and 2018 (units in thousands):
 202020192018
 Number of UnitsWeighted Average Price per Grant DateNumber of UnitsWeighted Average Price per Grant DateNumber of UnitsWeighted Average Price per Grant Date
Outstanding at January 1598 $92.19 539 $101.53 502 $90.96 
Granted172 37.44 172 75.09 113 125.73 
Granted for Performance Multiple (1)
66 100.95 72 69.43 72 101.87 
Released (2)
(223)88.52 (185)94.63 (148)84.43 
Forfeited— — — — — — 
Outstanding at December 31 (3)
613 (4)79.10 598 92.19 539 101.53 
(1)Upon completion of the Performance Period for the Performance Awards granted in 2016, 2015 and 2014, a performance multiple of 150%, 200% and 200%, respectively, was applied to each of the grants resulting in additional grants of Performance Awards in February 2020, 2019 and 2018.
(2)The total intrinsic value of Performance Awards released during the years ended December 31, 2020, 2019 and 2018 was $13 million, $15 million and $18 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date Performance Awards are released.
(3)The total intrinsic value of Performance Awards outstanding at December 31, 2020, 2019 and 2018 was $31 million, $50 million and $47 million, respectively. The intrinsic value is based on the closing market price of the Common Stock on the last trading day of the year.
(4)Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of 77 and a maximum of 1,149 Performance Awards could be outstanding.